FMC (FMC) announced that Isoflex active, the trade name for bixlozone, has received regulatory approval in the European Union. This approval is a critical milestone in FMC’s commercialization process, paving the way for the introduction of formulated products across more than 55M planted hectares of cereals, corn, oilseed rape and potato in the EU. Product dossiers have been submitted for these crops, and pending regulatory decisions, FMC anticipates launching products powered by Isoflex active beginning in 2027.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMC:
- Balancing Operational Stability and Elevated Risk: Rationale for Maintaining a Hold Rating
- FMC price target raised to $15 from $14 at Citi
- FMC says 5-10 parties ‘interested’ in company’s sales process
- FMC says running ‘Plan B’ to consider possible sale
- FMC price target lowered to $20 from $21 at Mizuho